Diurnal blood pressure variations in normoalbuminuric type 1 diabetic patients

Autor: M. Mau Pedersen, Jørgen S. Christiansen, Klavs Würgler Hansen, C. E. Mogensen

Publikováno v: Journal of Internal Medicine. 234:175-180

Objective. To test the hypothesis that normoal-buminuric type 1 diabetic patients segregate into groups with normal and elevated ambulatory blood pressure. To evaluate diurnal variation of blood pressure assessed by individual or fixed night-time per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65af8a46503bfcbe20d28667c89b36bb
https://doi.org/10.1111/j.1365-2796.1993.tb00727.x

Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients

Autor: C. E. Mogensen, Cramer Christensen, A. Schmitz, M. Mau Pedersen, Jørgen S. Christiansen, Klavs Würgler Hansen

Publikováno v: HANSEN, K W, PEDERSEN, M MAU, CHRISTENSEN, C K, CHRISTIANSEN, J S & MOGENSEN, C E 1992, ' Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients ', Journal of Internal Medicine, vol. 232, no. 2, pp. 161-167 . https://doi.org/10.1111/j.1365-2796.1992.tb00566.x

Recent reports have suggested that impaired renal function in type 1 diabetic patients may be present despite normal urinary albumin excretion (UAE). We have studied kidney function by means of a constant‐infusion technique in normoalbuminuric type

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4475b119053047dfa944c10186181ca
https://doi.org/10.1111/j.1365-2796.1992.tb00566.x

Lack of Effects of Angiotensinconverting Enzyme (ACE)-inhibitors on Glucose Metabolism in Type 1 Diabetes

Autor: Niels Møller, O. Rasmussen, T. Seefeldt, M. Mau Pedersen, Ole Schmitz, Jens Sandahl Christiansen, L. Ørskov, A. Mengel

Publikováno v: Diabetic Medicine. 7:700-704

To evaluate the impact of ACE-inhibitors on insulin-mediated glucose uptake, glucose-induced glucose uptake, and hepatic glucose production, a sequential glucose clamp was performed in eight normotensive Type 1 diabetic patients after 3 weeks of enal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c13257c64763a4f5e2d89fa80a1c29d
https://doi.org/10.1111/j.1464-5491.1990.tb01473.x

Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients

Autor: S. Engkjær Christensen, C. E. Mogensen, M. Mau Pedersen, J. Sandahl Christiansen, Hans Ørskov, E. Bjerregaard Pedersen

Publikováno v: Diabetic Medicine. 7:304-309

Suppression of growth hormone by means of somatostatin has been suggested as a possible adjunct therapy in Type 1 diabetes. To assess the acute effect of the somatostatin analogue SMS 201-995 on kidney function in uncomplicated Type 1 diabetes, 13 no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c465a0e606483ad296a604266f3c2ce
https://doi.org/10.1111/j.1464-5491.1990.tb01394.x

Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention

Autor: Salli Nielsen, C. E. Mogensen, Klavs Würgler Hansen, A. Schmitz, M. Mau Pedersen, Michael Rehling

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 22(1)

The principal end point in the evaluation of treatment in incipient and overt diabetic nephropathy is rate of decline in glomerular filtration rate (GFR). Therefore, information on reproducibility of GFR measurements is essential in the planning and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305095b00bad5c47479bcf43f6d10786
https://pubmed.ncbi.nlm.nih.gov/8322781